Mahmoud El Badry
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mahmoud El Badry has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Abeer Saad Hassan
Department of Pharmaceutics, Faculty of Pharmacy, South Valley University, Qena, Egypt
1 shared publication - Ahmed Mohammed Abd-Eldayem
Department of Medical Pharmacology, Faculty of Medicine, Assiut University, Assiut, Egypt
1 shared publication - Ahmed U. Ali
32- El sahel street, Assuit-Egypt
1 shared publication Amira A. Kamel
Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Assiut University, Assiut, Egypt
1 shared publicationEnas Mahmoud Amer
Botany and Microbiology Department, Faculty of Science, Assiut University, Egypt
1 shared publication- Gihan Fetih1 shared publication
Latest Publications
- Open Access
- 28 September 2026
- Published by Elsevier in SSRN Electronic Journal
Supramolecular stabilization of β-cyclodextrin–dendrimer/siRNA polyplexes using adamantane-functionalized cystamine polyethylene glycol
The development of nonviral carriers that simultaneously provide extracellular stability and efficient intracellular release remains a major challenge for small interfering RNA (siRNA) delivery. In this study, we developed a biocleavable supramolecular system by combining adamantane-functionalized cystamine-poly(ethylene glycol) (Ad-CYS-PEG) with a β-cyclodextrin–polyamidoamine dendrimer conjugate (β-CDE) through host–guest interactions. The resulting Ad-CYS-PEG/β-CDE complexes were designed to stabilize siRNA polyplexes under extracellular conditions while allowing intracellular dissociation through reduction of disulfide linkages. Successful synthesis of Ad-CYS-PEG was confirmed by 1H NMR spectroscopy. Agarose gel electrophoresis with heparin competition demonstrated enhanced polyplex stability compared with β-CDE alone, indicating stronger siRNA complexation following supramolecular assembly. Flow cytometric analysis using KB cells showed increased cellular uptake of Ad-CYS-PEG/β-CDE/siRNA complexes relative to β-CDE/siRNA polyplexes. Furthermore, the modified complexes exhibited negligible cytotoxicity under the experimental conditions evaluated. These findings demonstrate that biocleavable supramolecular complexation with Ad-CYS-PEG effectively improves the stability and cellular uptake of β-CDE-based siRNA polyplexes while maintaining favorable cytocompatibility. This host–guest assembly strategy represents a simple and adaptable platform for the design of biodegradable nonviral siRNA delivery systems and provides a foundation for future optimization toward functional gene silencing applications.
- 28 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessSupramolecular stabilization of β-cyclodextrin–dendrimer/siRNA polyplexes using adamantane-functionalized cystamine polyethylene glycol
The development of nonviral carriers that simultaneously provide extracellular stability and efficient intracellular release remains a major challenge for small interfering RNA (siRNA) delivery. In this study, we developed a biocleavable supramolecular system by combining adamantane-functionalized cystamine-poly(ethylene glycol) (Ad-CYS-PEG) with a β-cyclodextrin–polyamidoamine dendrimer conjugate (β-CDE) through host–guest interactions. The resulting Ad-CYS-PEG/β-CDE complexes were designed to stabilize siRNA polyplexes under extracellular conditions while allowing intracellular dissociation through reduction of disulfide linkages. Successful synthesis of Ad-CYS-PEG was confirmed by 1H NMR spectroscopy. Agarose gel electrophoresis with heparin competition demonstrated enhanced polyplex stability compared with β-CDE alone, indicating stronger siRNA complexation following supramolecular assembly. Flow cytometric analysis using KB cells showed increased cellular uptake of Ad-CYS-PEG/β-CDE/siRNA complexes relative to β-CDE/siRNA polyplexes. Furthermore, the modified complexes exhibited negligible cytotoxicity under the experimental conditions evaluated. These findings demonstrate that biocleavable supramolecular complexation with Ad-CYS-PEG effectively improves the stability and cellular uptake of β-CDE-based siRNA polyplexes while maintaining favorable cytocompatibility. This host–guest assembly strategy represents a simple and adaptable platform for the design of biodegradable nonviral siRNA delivery systems and provides a foundation for future optimization toward functional gene silencing applications.
- 1 July 2026
- Published by Scifiniti Publishing in Pharmaceuticals and Nanotech Connect
Nanoparticle-Based Vaccines: From Design and Immune Modulation to Clinical Translation
Vaccines are one of the most notable developments in modern medicine, and their role in combating and even eradicating diseases cannot be overlooked. Through an immunological cascade, vaccines produce an immunological memory response evident by memory cells and antibodies formation. Ever since the introduction of the first vaccine against smallpox, great efforts have been made to further improve vaccine efficacy, overcome limitations, and develop vaccines against emerging pathogens. The utilization of nanotechnology in vaccines has many benefits, as nanotechnology can address most of the limitations of traditional vaccines. Moreover, it has paved the path for the development of several vaccinations and is expected to continue contributing to future advancements. Nanoparticles have several types, with each type having its advantages and drawbacks. The physicochemical characteristics of these nanoparticles, namely particle size, particle shape, particle rigidity, surface charge, and hydrophobicity, affect the immune response potency. Optimization of these properties can allow the manufacture of vaccines that trigger strong immune responses. This strategic optimization permitted the production of effective vaccine formulations against several major pathogens in the market. Notable nanoparticle vaccines include the human papillomavirus, malaria, hepatitis B, and severe acute respiratory syndrome coronavirus 2 vaccines. This comprehensive review explores the vaccine immunological cascade, the platforms of nanoparticles, their advantages and drawbacks, and the impact of their physicochemical characteristics on vaccine efficacy. Moreover, this review highlights the nanovaccine formulations that have been approved for use.
- 1 July 2026
- Published by Scifiniti Publishing in Pharmaceuticals and Nanotech Connect
Nanoparticle-Based Vaccines: From Design and Immune Modulation to Clinical Translation
Vaccines are one of the most notable developments in modern medicine, and their role in combating and even eradicating diseases cannot be overlooked. Through an immunological cascade, vaccines produce an immunological memory response evident by memory cells and antibodies formation. Ever since the introduction of the first vaccine against smallpox, great efforts have been made to further improve vaccine efficacy, overcome limitations, and develop vaccines against emerging pathogens. The utilization of nanotechnology in vaccines has many benefits, as nanotechnology can address most of the limitations of traditional vaccines. Moreover, it has paved the path for the development of several vaccinations and is expected to continue contributing to future advancements. Nanoparticles have several types, with each type having its advantages and drawbacks. The physicochemical characteristics of these nanoparticles, namely particle size, particle shape, particle rigidity, surface charge, and hydrophobicity, affect the immune response potency. Optimization of these properties can allow the manufacture of vaccines that trigger strong immune responses. This strategic optimization permitted the production of effective vaccine formulations against several major pathogens in the market. Notable nanoparticle vaccines include the human papillomavirus, malaria, hepatitis B, and severe acute respiratory syndrome coronavirus 2 vaccines. This comprehensive review explores the vaccine immunological cascade, the platforms of nanoparticles, their advantages and drawbacks, and the impact of their physicochemical characteristics on vaccine efficacy. Moreover, this review highlights the nanovaccine formulations that have been approved for use.
- 7 October 2023
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 90
Serum levels of tumor necrosis factor (TNF-α) and vaginal gene expression of toll-like receptor 2 (TLR2) & microtubule-associated protein 1 light chain 3 (LC3) after treatment of vulvovaginal candidiasis with sertaconazole nitrate spanlastics
- 7 October 2023
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 90
Serum levels of tumor necrosis factor (TNF-α) and vaginal gene expression of toll-like receptor 2 (TLR2) & microtubule-associated protein 1 light chain 3 (LC3) after treatment of vulvovaginal candidiasis with sertaconazole nitrate spanlastics